Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
VETPHARM from Izegem, company number BE0839331991, closed financial year 2025 with a result of € 31,770 after tax. For that financial year VETPHARM recorded a gross margin of € 124,072 and equity of € 937,060. Compared with financial year 2024, the result moved from € 376,696 to € 31,770. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 937,060
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 31,770
▼ 92% vs 2024
Profit after tax over the fiscal year.
€ 67,101
▲ € 54,483 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 897,060.
People and assets in 2025
€ 2,645
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.5 million
▲ 64% vs 2024
€ 523,549 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 2.8 million
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 249,070 | € 272,585 | € 505,635 | € 124,072 | ▼ 75% |
| Profit after taxes | € 93,592 | € 92,637 | € 376,696 | € 31,770 | ▼ 92% |
| Equity | € 597,958 | € 598,594 | € 905,290 | € 937,060 | ▲ 4% |
| Total debts | € 3,580,444 | € 4,933,061 | € 6,094,856 | € 4,633,500 | ▼ 24% |
| Cash | € 31,587 | € 182,080 | € 12,618 | € 67,101 | ▲ € 54,483 |
| Retained profit | € 557,958 | € 558,594 | € 865,290 | € 897,060 | ▲ 4% |
| Dividend | € 93,600 | € 92,000 | € 70,000 | € 0 | ▼ 100% |
| Bank debt | € 851,216 | € 1,438,097 | € 942,567 | € 1,542,813 | ▲ 64% |
| Balance sheet total | € 4,178,401 | € 5,531,656 | € 7,000,146 | € 5,570,560 | ▼ 20% |
| Employees (FTE) | 1.3 | 0.3 | - | - |
Key figures of VETPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VETPHARM?
What happened at VETPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 31,770 (▼ 92% vs 2024). Source: NBB ↗
- New establishment in Izegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 93,592 profit in 2022 to € 31,770 profit in 2025.
Paid € 180,755 in corporate taxes since 2022.
Best year ever: 2024, with € 376,696 profit.
On average € 191,600 of value added per employee in 2022.
A new publication or filing at VETPHARM? We notify you, reason included.
Follow VETPHARMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VETPHARM is De Sasmeester CommV. De Sasmeester CommV is also behind WAAROOST, IMAQUA, WAAROOST APOTHEEK, RUMEXPERTS and C-Path.
Directors
According to the 2025 annual accounts
Director · represented by Joris Pieter De Gussem
Also active at: WAAROOST, IMAQUA, WAAROOST APOTHEEK, RUMEXPERTS, C-Path, POULPHARM, MYVO
Establishments
Establishment units
Physical locations of this company
Kokelarestraat 83
8870 Izegem
Noordkaai 24
8870 Izegem
Active since 15 December 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →DE SASMEESTER same network
MANDELSAS
POULPHARM same network
€ 17 million revenue · 2025
MYVO same network
€ 2.2 million gross margin · 2025
PHAGOMED
€ -889 gross margin · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0839.331.991
- VAT number
- BE 0839.331.991
- Registered office
- Kokelarestraat 83, 8870 Izegem
- Names & denominations
- VETPHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 August 2011
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Groothandel in farmaceutische en medische artikelen